Keyphrases
Amino Acid Sequence
6%
Anthracis
7%
Antibody Response
8%
Bacillus Anthracis
7%
Bacteriophage
5%
Biobank
7%
Care Homes
23%
Causative Agents
6%
Clinical Samples
5%
Commercially Available
9%
Confidence Interval
5%
Convalescent
6%
Convalescent Plasma
7%
Convalescent Plasma Therapy
9%
Coronavirus
6%
COVID-19
100%
COVID-19 Outbreak
14%
Crimean-Congo Hemorrhagic Fever
7%
Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
5%
Cycle Threshold
12%
Detergent
7%
Ebola
15%
Ebola Outbreak
11%
Ebola Virus
36%
Ebola Virus Disease
7%
Ebola Virus Infection
8%
Endothelial Cells
7%
Enzyme-linked Immunosorbent Assay (ELISA)
5%
Europe
6%
Exocytosis
25%
Ferret
7%
Guinea pig Model
6%
Healthcare Workers
11%
Herpes Simplex Virus 2 (HSV-2)
5%
Highly Pathogenic
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
In Care
9%
Infectious Virus
7%
Influenza A
7%
Laboratory Confirmation
7%
Live Attenuated Influenza Vaccine
7%
Makona
7%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
12%
Ministry of Health
7%
Monkeypox
5%
Monoclonal Antibody
11%
Mouse Model
5%
Mouthwash
7%
Multicenter Cohort Study
7%
Natural Infection
5%
Neutralizing Antibodies
27%
Nucleic Acid Extraction
6%
Omicron Variant
7%
Outbreak Investigation
9%
Parafilm
7%
Patient Samples
5%
PCR Cycles
6%
PCR Test
9%
Plasma Membrane
7%
Poliovirus
7%
Polymerase Chain Reaction
9%
Polymerase Chain Reaction Assay
5%
Primary Container
7%
Provirus
8%
Public Health England
13%
Q Fever
11%
Quantitative PCR
37%
Rab27a
8%
Receptacle
7%
Recombinant
5%
Reinfection
15%
Saliva
6%
Sample Transportation
8%
Sanitation
7%
SARS-CoV-2 Infection
16%
SARS-CoV-2 Outbreak
7%
SARS-CoV-2 Variants
9%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
10%
Sierra Leone
11%
Siren
7%
Surface Sampling
10%
Synaptotagmin
8%
Targeting Antibodies
5%
Transmissibility
7%
Uganda
9%
Ugandan
9%
United Kingdom
21%
Viable Virus
6%
Vietnam
7%
Viral Hemorrhagic Fever
7%
Virion
7%
Virus
48%
Virus Challenge
8%
Virus Isolation
5%
Virus RNA
7%
Virus-neutralizing Antibody
5%
Von Willebrand Factor
10%
Weibel-Palade Bodies
19%
West Africa
10%
Workplace
10%
Immunology and Microbiology
Amino Acid Sequence
6%
Antibody Response
7%
Bacillus Anthracis
7%
Bacteriophage
5%
Blood Plasma
21%
Cell Membrane
8%
Cell Surface
5%
Cladistics
6%
Coronavirinae
9%
COVID-19
11%
Dynamics
8%
Ebola Virus
43%
Enzyme-Linked Immunosorbent Assay
5%
Epitope
7%
Exocytosis
29%
Glycoprotein
5%
Guinea Pig
6%
Guinea Pig Model
5%
Hemorrhagic Fever
8%
Human Immunodeficiency Virus 1
9%
Human Monoclonal Antibody
7%
Immunoassay
7%
Immunodeficiency
7%
Influenza
15%
Influenza Vaccine
7%
Lineages
8%
Middle East Respiratory Syndrome Coronavirus
8%
Monoclonal Antibody
6%
Mouse Model
5%
Mustela Putorius Furo
7%
Neutralization
6%
Neutralizing Antibody
19%
Normal Human
5%
Omicron Coronavirus Variant
7%
P-Selectin
6%
Poliomyelitis Virus
7%
Provirus
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Receptor Binding
5%
Reverse Transcription Polymerase Chain Reaction
6%
SARS Coronavirus
6%
Secretion (Process)
8%
Serotype
5%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Spike
13%
Viral Disease
10%
Viral Shedding
7%
Virion
7%
Virus
39%
Virus Antibody
5%
Weibel Palade Body
19%
Wild Type
7%
Medicine and Dentistry
Cohort Analysis
5%
COVID-19
30%
Crimean-Congo Hemorrhagic Fever
7%
Diseases
9%
Ebolavirus
30%
Endothelial Cell
14%
Exocytosis
13%
Guanidine
7%
Health Care
14%
Human Immunodeficiency Virus
7%
Immunoassay
5%
In Vitro
8%
Infection
42%
Infection Control
5%
Lid
7%
Mouthwash
7%
Neutralizing Antibody
17%
Nucleic Acid
7%
Polymerase Chain Reaction
5%
Prevalence
5%
Public Health
18%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Reinfection
11%
Reverse Transcription Polymerase Chain Reaction
7%
SARS Coronavirus
6%
Sensitivity and Specificity
6%
Severe Acute Respiratory Syndrome
6%
Severe Acute Respiratory Syndrome Coronavirus 2
84%
Synaptotagmin
8%
Virus
23%
Virus Infection
9%
Virus Isolation
5%
Von Willebrand Factor
7%
Weibel-Palade Body
11%